Transcription profiling of human prostate carcinoma cell line PC3 treated with reverse transcriptase inhibitor abacavir
Ontology highlight
ABSTRACT: Human prostate carcinoma cell line PC3 was treated with 10mg/ml or 100mg/ml of Abacavir. Gene expression was analyzed on total RNA extracted 48h after treatement. For each condition, 5 indipendent biological replicates were performed
ORGANISM(S): Homo sapiens
SUBMITTER: Simona Gaudi
PROVIDER: E-TABM-532 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA